Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2019-12-20 2019-12-20
Drug Identification Number 02258560 02258560
Brand name TRI-CYCLEN LO (-21 DAY) TRI-CYCLEN LO (-21 DAY)
Common or Proper name norgestimate and ethinyl estradiol tablets norgestimate and ethinyl estradiol tablets
Company Name JANSSEN INC JANSSEN INC
Ingredients ETHINYL ESTRADIOL ETHINYL ESTRADIOL ETHINYL ESTRADIOL NORGESTIMATE NORGESTIMATE NORGESTIMATE ETHINYL ESTRADIOL ETHINYL ESTRADIOL ETHINYL ESTRADIOL NORGESTIMATE NORGESTIMATE NORGESTIMATE
Strength(s) 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1x10 1x10
ATC code G03AB G03AB
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-06-30 2020-06-30
Actual discontinuation date
Remaining supply date 2020-06-30 2020-06-30
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments